Crystal-induced oligoarthritis triggered by pembrolizumab, an immune checkpoint inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Crystal-induced oligoarthritis triggered by pembrolizumab, an immune checkpoint inhibitor

Published:2018-10 Issue:5 Volume:85 Page:647-648
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Corominas Hèctor^ORCID,Badlissi Fadi,Shmerling Robert H.

Publisher

Elsevier BV

Subject

Rheumatology

Reference10 articles.

1. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

2. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (Keynote-002): a randomised, controlled, phase 2 trial;Ribas;Lancet Oncol,2015

3. Safety of pembrolizumab for the treatment of melanoma;Martin-Liberal;Expert Opin Drug Saf,2015

4. Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials;Hao;Medicine (Baltimore),2017

5. Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: a meta-analysis;Wang;Front Pharmacol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium pyrophosphate crystal arthritis associated with immune checkpoint inhibitor successfully treated with intra-articular glucocorticoid: A case report;Modern Rheumatology Case Reports;2024-05-16

2. Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis;Rheumatic Disease Clinics of North America;2024-05

3. Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications;Arthritis & Rheumatology;2021-03-05

4. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors;Annals of the Rheumatic Diseases;2020-04-23

5. Ipilimumab/nivolumab/pembrolizumab;Reactions Weekly;2019-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3